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Abstract: We explore the feasibility of using gold nanorods with efficient 
two-photon luminescence properties as contrast agents for intravital imaging 
of neoplasia. This investigation spanned ex vivo characterization in 
cells/tissue to in vivo implementation in an oral carcinogenesis model. 
GNRs were >40 times brighter than surrounding tissue. Intravital imaging 
revealed 3D microvasculature, and in dysplasia, abnormal vessels (dense 
and tortuous) compared to normal. GNRs were diffusely distributed in 
lesions after 24 hours. No known previous study has revealed abnormal 
vessel structure in dysplasia by imaging. Results suggest GNRs can function 
as high-contrast agents for in vivo visualization of carcinogenesis features. 
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1. Introduction 
Highly efficient nanoparticles exhibiting two-photon induced photoluminescence are of great 
interest as contrast agents for in vivo optical imaging, including molecular imaging of cancer, 
due to their ability to be excited with extremely low incident powers, their well-defined 
spectral properties, and their potential for enabling large imaging depths using intravital two-
photon microscopy [1,2]. Gold nanorods (GNRs) exhibit very bright two-photon 
luminescence (TPL) signals that have been shown to be many times brighter than traditional 
fluorophores, such as rhodamine or native fluorophores [3,4]. GNRs can also be 
bioconjugated to enable molecular targeting [4–6]. Additionally, gold is considered a 
relatively biocompatible material compared to other nanoparticle materials, and has promising 
applications in preclinical in vivo imaging [6,7]. Previous studies demonstrating the potential 
benefits of GNRs as high contrast TPL agents for cancer imaging have been reported for 
studies performed in cell cultures or tissue phantoms [4,8]. One known study has imaged 
GNRs in vivo for clearance and biodistribution characterization in mice [9]. Gold nanoshells 
have been imaged in vivo and though one study found their properties to be comparable to 
GNRs, only nanoshells were delivered in vivo [2]. No known reports have demonstrated the 
potential use of GNRs as contrast agents for intravital multi-photon imaging in neoplasia. 
Epithelial neoplasms account for the majority of cancers, and although they occur at 
epithelial surfaces, they can span several hundred microns in depth. One of the primary 
challenges for treating cancer is early detection. In fact, the probability for cancer survival is 
significantly correlated with its stage of development at diagnosis. For example, in the case of 
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oral cancer, which is associated with a 5-year survival rate of 55%, patients with a localized 
malignancy have a survival rate of 82%, compared to a survival rate of 46% in patients where 
the disease has spread to adjoining areas, and 21% after metastasis [10,11]. Thus, it is thought 
that one of the most effective ways to battle cancer is through early detection, before it 
metastasizes, when it is still possible to successfully treat local occurrence with conventional 
techniques such as chemotherapy or surgical removal. Furthermore, oral cancer is associated 
with a high recurrence rate which has a higher morbidity and mortality than primary 
occurrence, necessitating early detection of recurrence as well as margin identification [12]. 
There is a clear need for the development of robust and sensitive detection methods for 
identifying high risk premalignant (e.g. dysplasia) and malignant regions during early stages 
of neoplastic transformation. In recent years, there has been a growing recognition for the 
need to develop new imaging techniques that can be combined with efficient contrast agents, 
including molecular-specific agents, to reveal early neoplastic changes [13]. Such capabilities 
would be highly beneficial for the enhanced understanding of the multi-step process of 
epithelial carcinogenesis, toward assessment of candidate therapies, and toward developing 
effective early diagnostic approaches. Two-photon microscopy is a particularly attractive 
possibility as imaging depths are sufficient to image both epithelium and stromal components 
of oral mucosal tissue [14,15]. Although two-photon microscopy has been explored for in vivo 
imaging of oral squamous cell carcinoma (SCC), image contrast in previous studies has thus 
far primarily been provided by autofluorescence (AF) [16–20]. 
GNRs as TPL contrast agents could be highly useful for delineating areas of abnormality 
versus surrounding normal tissue in oral carcinogenesis. In this study, we present two-photon 
induced luminescence imaging of nontargeted GNRs in an in vivo animal model for oral 
carcinogenesis. Potential benefits of the gold nanorods are explored for providing contrast to 
visualize subsurface details of abnormal vasculature in precancerous lesions (dysplasia) using 
very low incident powers where autofluorescent background is not detected. Quantitative 
image parameters describing vessel properties are qualitatively correlated to histology 
observations. 
2. Materials and methods 
2.1. Two photon microscopy system 
Two-photon microscopy was performed on a custom-built system based on a modification of 
a Zeiss Confocal LSM 410 microscope and outfitted with optics designed for ultrafast laser 
excitation and nondescanned detection of multiphoton emission [14]. The excitation source 
was a femtosecond Ti:sapphire laser (Tsunami, Spectra Physics/Newport, Irvine CA) having a 
5W frequency-doubled Nd:YVO pump laser. The system operated with a typical pulse width 
of 140 fs prior to the objective (40x 0.8 N.A. water). An epi-configuration was used for 
collection of emitted light and detected using a cooled PMT placed in a nondescanned 
configuration (R6060, Hamamatsu, Japan). Emission was collected in the range of 450-650 
nm. Imaging field of view was 320 x 320 µm and a z-interval of 1 µm was used for acquiring 
zstacks. Image reconstructions of two-photon micrograph stacks were performed using Imaris 
3D visualization software (Bitplane Inc., St. Paul, MN). Confocal reflectance microscopy in 
the case of surface tissue imaging to demonstrate surface features of areas imaged by TPL was 
accomplished using the same microscope and objective in confocal mode, operating at an 
illumination wavelength of 568 nm from an Ar:Kr ion laser. Reflected light in confocal 
reflectance microscopy was collected using a cooled PMT (R6060, Hamamatsu, Japan) along 
the descanned confocal path. 
Spectral profiles of GNRs were obtained using a microspectroscopy unit adapted to the 
detection port of the two-photon microscope. The unit consisted of a 300 g/mm grating 
spectrograph (SpectraPro-150, Princeton Instruments) and a computer-controlled electron 
multiplying CCD camera (Newton DU970N, Andor Technology) mounted to the exit port of 
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the spectrograph. Calibration of the system was performed using a mercury-argon light source 
and the final spectra were corrected for the optical transmission characteristics of the 
microscope. The spectral window of the spectroscope ranged from approximately 200 nm to 
700 nm with a resolution of 0.1 nm per pixel. A lateral displacement mirror angled at 45° was 
used to direct the TPL signal to either the spectrograph for spectroscopy or photomultiplier for 
imaging. 
2.2. Gold nanorods 
Commercially available GNRs were used for these studies (Nanopartz Inc., Loveland CO). 
GNRs were 10x38 nm in dimension and had a longitudinal surface plasmon resonance 
(LSPR) peak at 780 nm and a transverse surface plasmon resonance (TSPR) peak at 512 nm. 
2.3. Cells and animal model 
In this study, we first characterized the GNRs in cells to establish expected image parameters 
in tissues and in the in vivo oral precancer/cancer model. Oral squamous cell carcinoma cells 
(JHU-19) were seeded onto poly-D-lysine coated imaging dishes having a #1.5 coverslip 
bottom (Matek Corporation, Ashland, MA) and allowed to reach confluence [21]. Cells were 
then incubated with methyl-terminated Ntherapy GNRs (Nanopartz Inc., Loveland, CO). For 
incubation, 20 µl of 100 nM Ntherapy GNR stock (optical density 50) was added to 2 ml 
Dulbecco's Modified Eagle Medium (DMEM) without phenol red for time periods ranging 
from 10 minutes to 24 hours. The 2 hour time point was found to be acceptable due to high 
uptake of the GNRs and thus, in subsequent imaging, a 2 hour incubation time was used. Prior 
to imaging, cells were viewed under bright field microscopy to visualize morphology of cells 
and attachment to the imaging dish. Samples were rinsed with PBS to remove excess GNRs. 
Unlabeled cultures underwent the same procedures except for the delivery of GNRs. Two-
photon microscopy imaging of labeled and unlabeled cells was performed using a range of 
incident powers from 0.2 mW to >6 mW and incident power versus emission signal plots 
were created. 
Animal studies were performed in a hamster model for oral precancers and cancer. Oral 
carcinogenesis was induced in the buccal pouch of Golden Syrian hamsters by thrice-weekly 
topical application of 0.5% 9,10-dimethyl-1,2-benzanthracene (DMBA). This is a widely 
accepted model that closely mimics the stages of precancers and oral squamous cell 
carcinoma in humans both in histology and in the expression of key molecular biomarkers 
[22–24]. Hamsters received DMBA treatment for 12 weeks, after which a variety of 
preneoplastic and neoplastic lesions were present throughout the buccal mucosa. 
2.4. Ex vivo imaging 
For  ex vivo studies, hamsters were first anesthetized using a mixture of Ketamine 
(100mg/kg)/Xylazine (10mg/kg) mixture given i.p. The buccal pouch was everted and secured 
to a flat sample holder which interfaced onto the microscope stage for imaging. The 
anesthetized hamster was held in a supine position to access the sublingual surface where the 
sublingual veins (V. sublingualis) run from basis to the apex of the tongue. An intravenous 
(i.v.) injection of GNRs (0.2 cc of 100 nM (50 optical density) (Ntrackers, Nanopartz)) into 
the sublingual vein was given using a 26 gauge needle and the time of injection was noted The 
hamster was then placed on the imaging stage, and two-photon imaging commenced 10 
minutes following the noted time of injection, targeting the microvasculature in the in vivo 
buccal pouch to confirm the successful delivery of the GNRs into the vascular space. Visible 
lesions having the appearance of leukoplakia or early tumor masses were biopsied 24 hours 
post injection. Leukoplakia are clinically identifiable white patches that may range from 
histologically-defined hyperkeratosis, dysplasia, carcinoma-in situ (CIS), or invasive SCC; in 
the hamster model they are commonly dysplasia, a precancerous condition [25]. Samples were 
imaged (in vitro) and signal intensity versus incident power was then characterized and 
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averaged for 3 animals (2-3 areas evaluated per lesion) at a consistent depth of 60 µm. 
Identical procedures were followed for unlabeled oral samples at the same imaging depth. The 
presence of GNRs in lesions was validated by 1) confirming low powers could be used to 
induce emission (0.2-0.7 mW as in the cell studies), 2) confirming the nonlinear nature of 
emission signal by observing the loss of signal with removal of laser modelock, and 3) 
qualitative characterization of excitation spectral response by loss of signal as laser was tuned 
away from the 780 nm absorption peak. 
2.5. In vivo imaging 
Hamsters were anesthetized and the buccal pouch secured to a sample holder for imaging as 
described above. In vivo imaging was performing on 5 DMBA hamsters and 2 untreated of 
comparable age. In this case visually identified lesion sites in DMBA hamsters and normal 
sites in control hamsters were imaged in vivo prior to i.v. delivery of GNRs as described 
above, at 10 minutes, and 24 hours with z-stacks obtained up to a depth of 230 microns. Sites 
of interest were located using a 10x 0.3 N.A. objective and images were collected using the 
40x objective. A single confocal image was obtained of the imaged sites prior to the 
acquisition of a two photon z-stack. Biopsies were obtained at 24 hours and samples were 
immersed in formalin for fixation for 24 hours, then embedded in paraffin, sectioned, and 
stained with hematoxylin and eosin (H&E) for histological examination by a board certified 
pathologist (SQ). 
To quantify vessel features, reconstructed 3D TPL images of the vascular network of 
dysplastic and normal sites were evaluated for 1) number of vessel branch junctions and 2) 
distance between branch junctions (vessel segment length). This was performed in a blinded 
manner with graders unaware of the pathological state of the imaged site. To measure distance 
between branch junctions, all vessel segments connecting two branch points/junctions were 
visually identified, then a line tool was manually drawn along the length of each segment to 
measure the distance of each segment in microns, keeping the line in the center of the vessel. 
Curved lines were used to capture the segment length of those vessels that were curved. The 
average line segment length was then calculated for each sampled site and an average taken 
per group (normal vs. dysplastic lesions). Quantification of vessel branch junction numbers 
was completed by manually counting all identified branch junctions per imaged sample and 
determining the average value for each group. Two of the image reconstructions were not of 
high enough quality to quantitatively measure morphometric features (although visually the 
increased vessel density and tortuous nature was evident) and were not included in the 
quantitative analysis. A Verhoeff-Van Gieson (VVG) stain was used to confirm presence of 
vessels within H&E sections. For each biopsy, a vessel count was performed on VVG stained 
single sections at 40x magnification 
3. Results and discussion 
Figure 1 presents typical two-photon images of labeled and unlabeled cells excited with 780 
nm. Cells that had been incubated with GNRs typically had signals distributed throughout the 
cytoplasm, with nuclei appearing as dark regions, such as in the central dark regions of cells 
shown in the maximum intensity projection image of Fig. 1a, shown from a viewpoint of 0 
degrees. Presence of GNR signal in the cytoplasm and periphery can be visualized in Fig. 1b, 
where cells were labeled with GNRs and subsequently with 5 µM Calcein-AM, a live cell 
stain. Cells were imaged using 0.4 mW for isolating GNR signal then at high power (8 mW) 
to capture Calcein-AM fluorescence. Single planes (xy, xz, yx) taken through the center of the 
larger cell demonstrate the localization of GNR signal within the cell as well as near the 
periphery. Figures 1d and e show overlays of TPL channel with transmitted light images of 
cells labeled (1d) and unlabeled (1e) with GNRs. Samples labeled with GNRs were 
illuminated with incident powers as low as 0.2 mW, which resulted in an average signal-to- 
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Fig. 1. Two-photon induced luminescence images of GNR-labeled and unlabeled JHU-19 oral 
squamous cell carcinoma cells. (a) Two-photon maximum intensity projection image of GNR-
labeled cells using an incident power of 0.7 mW (image has been cropped to a dimension of 
~50 by 50 microns to show details of cells). GNRs are distributed throughout cytoplasm, with 
nuclei appearing dark; (b) image of GNR labeled cell subsequently labeled with the live cell 
dye Calcein-AM, shown in red. Three planes through the midline of the cell are shown along 
three-dimensions (x-y, x-z,y-z) . (c) Graph demonstrating quadratic dependence of emission 
signal intensity on incident laser power. Slope of fitted line is 1.96; (d) Two-photon image of 
GNR-labeled cells using an incident power of 0.7 mW overlayed with corresponding 
transmitted light micrograph (e) Two-photon overlay image of unlabeled cells also using an 
incident power of 0.7 mW with detector and optical path settings unchanged.. Imaging was 
performed using a 40x 0.8 N.A. water immersion objective. 
background ratio of 9.5, thus easily detected. Using an incident power of 0.7 mW, as in the  
case exhibited in Fig. 1d, resulted in a signal-to-background ratio of 24.9. No detectable signal 
was observed using equivalent incident laser powers on control (unlabeled) cells, as shown in 
Fig. 1e. Keeping all other conditions the same, incident laser powers greater than 35 mW were 
necessary to acquire similar signal-to-background values from native autofluorescence in 
unlabeled cells. Taking the laser out of mode-lock while illuminating the sample with the 
same incident power resulted in the disappearance of the signal from GNR labeled cells – 
confirming the detected signal to be nonlinear in nature. As shown in Fig. 1c, the TPL 
intensity (arbitrary units) was characterized as a function of power incident on the sample to 
confirm the quadratic dependence expected from a TPL response. A linear fit on the log-log 
plot of the data resulted in a slope of 1.96, confirming the expected quadratic dependence. 
Finally, microspectroscopy performed on the nanorods resulted in similar emission spectra to 
published results (shown in Fig. 3e) [3,4]. Thus, in these initial studies we confirmed the basic 
TPL characteristics of the GNRs and demonstrated their brightness in cells before 
implementing in vivo delivery. 
In order to evaluate the potential benefits of GNRs for in vivo imaging, we performed tests 
to compare the luminescence signal from GNRs to that from native fluorophores in ex vivo 
oral mucosa tissue. Figure 2 shows the TPL response as a function of incident power for both 
autofluorescence and GNRs. This plot demonstrates significantly lower incident powers are 
required to excite GNRs than native fluorophores in order to obtain equivalent emission 
signals. Additionally, the quadratic dependence of the emission signal on incident power level 
was confirmed in both cases through a linear fit of the log-log plot, which had slopes of 
approximately 2; thus the signal detected was a two-photon signal. The expected signal 
difference between GNR TPL and AF TPL was found by determining the difference between  
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Fig. 2. Average trends displaying emission signal intensity vs. incident laser power for cases of 
gold nanorods and autofluorescence. In both cases, the quadratic dependency of two-photon 
emission signal on incident laser power was confirmed (the slope of a fitted line to log-log 
plots was ~2 for each case). 
intercepts of the two log plots, resulting in a factor of 44 for this case. This value is reasonable 
given other studies have reported GNRs to be 50-60 times brighter than traditional 
fluorophores or native fluorophores in cells [3,4]. Since native autofluorescence can 
contribute substantial optical background signals when imaging with exogenous fluorophores, 
the absence of native autofluorescence at incident power levels where GNRs can be detected 
would benefit tissue imaging studies by reducing background signals that could affect 
interpretation of images. Another advantage in the use of GNRs is the desire to minimize the 
average powers incident on tissue. Thus, these ex vivo imaging studies in oral mucosa tissue 
with high autofluorescence and tissue having GNRs helped established the benefits of these 
contrast agents for allowing imaging in depth without confounding background 
autofluorescence while using low incident powers. 
In vivo imaging: The results of in vivo imaging of non-targeted GNRs within the 
microvasculature of the normal hamster buccal pouch are demonstrated in Fig. 3. Confocal 
reflectance and multiphoton autofluorescence micrographs were taken prior to in vivo 
intravenous delivery of the GNRs; in both cases, blood vessels appear dark compared to 
surrounding tissue (Figs. 3a and 3b). It is worth noting that an incident power of 20 mW was 
needed to obtain the multiphoton autofluorescence micrograph displayed, and it was 
confirmed that up to this high incident power, no emission signal was detected from the 
vessels. In contrast, the image shown in Fig. 3c was obtained following intravenous injection 
of the GNRs using an incident power of 1 mW at a depth starting at 60 µm (to 175 µm) at the 
same vessel site shown in Figs. 3a and 3b. As can be seen in Fig. 3c, using GNRs as a contrast 
agent, microvasculature in this normal site can easily be visualized using low incident powers 
that are sub-threshold for obtaining background autofluorescence. 
The spectral profile shown in Fig. 3d for the ex vivo GNRs was similar to those that have 
been previously reported in the literature in ex vivo experiments [3,4]. As shown in Fig. 3d, 
the in vivo and ex vivo spectra are identical except for slight differences in the 400-450 nm 
range. These differences are attributed to reabsorption and scattering of this lower wavelength 
light in tissue, such as reabsorption by hemoglobin. Thus, despite this slight difference, the in 
vivo microenvironment did not significantly alter the spectral properties of the GNRs. 
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Fig. 3. Representative two-photon microscopy images of intravenously delivered GNRs in 
hamster model with accompanying confocal reflectance image (a) Confocal reflectance image 
of tissue showing location of blood vessels which appear dark against the surrounding tissue 
(b) High power (20 mW) two photon image of the same vascular region prior to intravenous 
injection of GNRs (c) Two-photon image using low incident power of 1 mW following 
intravenous injection GNRs showing blood vessels in the tissue. Two-photon microscopy of 
vascular sites prior to GNR injection, using 1-20 mW incident power, yielded no detectable 
signal from blood vessels. Asterisk denotes the same vessel junction on all three images 
displayed. (d) Spectral profile of GNRs in vitro and within in vivo blood vessels following 
intravenous injection. 
Intravenous injection of GNRs into DMBA-treated animals allowed for the abnormal 
vascular structure of the dysplastic mucosa to be visualized using low incident powers ranging 
from 0.2 mW to 1 mW, and up to 230 microns in depth without the presence of confounding 
autofluorescence. The microvasculature of DMBA-transformed mucosa at 10 minutes 
appeared highly dense and tortuous with more branching points than those of normal oral 
mucosa such as the case in Fig. 3c (Fig. 4a). 
Two-photon image of lesion 24 hours post-inoculation using same incident power of 1 
mW. In this case GNRs are distributed throughout the volume of the imaged lesion, rather 
than confined to the vascular space (c) Confocal reflectance image acquired at 10x 
magnification used to microscopically identify lesion surface prior to two-photon microscopy. 
Asterisk denotes image artifact. (d) Histology of lesion, stained with VVG stain. Some 
identified vessels are located at sites of the asterisks (*). 
Interestingly, blood vessel counts in stained histology sections revealed significantly more 
vessels in single sections from dysplastic sites than normal sites, as indicated in Table 1. 
Analyzed TPL images revealed that dysplastic sites had an increased number of vessel 
junctions and were highly tortuous (decreased distance between vessel branch junctions). 
Histology slides provide a single slice view of a tissue site, whereas 3D volumes are provided 
in TPL. While a direct comparison of vessel numbers between histology sections and 3D TPL 
is challenging and beyond the scope of the current study, in TPL the increased density of 
vessels, the decreased distance between vessel branch junctions, and increased number of 
vessel junctions provide a basis for why more vessels are seen in histology cross-sections. 
Post-injection, GNRs were allowed to circulate for 24 hours and then sites were re-imaged 
with two-photon microscopy to visualize GNR distribution in the lesion sites at that time 
point, followed by biopsy. Typical results indicated a diffused pattern of GNR distribution,  
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Fig. 4. (a) Two-photon 3D reconstructed image of precancerous (dysplastic) lesion labeled with 
GNRs 10 minutes post-inoculation, showing dense and tortuous network of blood vessels, 
obtained with an incident power of 1 mW. (b) 
Table 1. Comparison of blood vessel features in histology and TPL
a 
   TPL  Image  Parameters 
 
Histology Evaluation
# of Vessels 
Ave Vessel 
Segment Length  Vessel Junctions 
Normal  0.8 ± 0.5  111 ± 19  6 ± 2 
Dysplasia  8.3 ± 2.5  44 ± 10  16 ± 4 
aSingle VVG stained sections from lesions and control sites were assessed for number of blood vessels in the 
histology evaluation. In TPL, the number of vessel junctions and the distance between vessel branch junctions (vessel 
segment length) were obtained in imaged volumes. The decreased vessel segment length and increased number of 
vessel junctions in DMBA-treated (dysplastic) sites indicate measures of increased vessel density and abnormal 
structure and are consistent with the increased number of vessel counts in histology sections. 
which did not appear to be confined within vessel sites, but rather distributed throughout the 
lesion area (Fig. 4b). GNRs were still clearly confined to the microvasculature. In contrast to 
dysplastic sites, the microvasculature of normal sites and control animals not treated with 
DMBA still had circulating GNRs after 24 hours. This observed difference between the 
apparent distributions of GNRs in dysplastic lesions as compared to normal oral tissue is 
possibly due to passage of the GNRs into the lesion space from the abnormal 
microvasculature, which would occur if the blood vessels were leaky. A hallmark of tumor 
angiogenesis is abnormal blood vessels which are leaky [26]. Interestingly, recent evidence of 
the presence of angiogenesis in dysplasia has been shown (including dysplasia of the oral 
mucosa) [27–29]. Thus, given these recent findings, it would be expected that vessels of 
dysplastic lesions be leaky compared to normal vessels. This feasibility study sets the stage 
for a broader in vivo angiogenesis imaging study using GNRs. 
4. Conclusions 
In this study, the feasibility of using GNRs as efficient contrast agents for in vivo imaging of 
features of oral carcinogenesis was evaluated following cellular and in vitro characterization 
of their properties. We found GNRs to be useful in visualizing the abnormal 3-dimensional 
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vascular structure present in dysplastic oral mucosa using much lower incident powers than 
those needed for autofluorescence and for typical fluorophores on our system. Images 
revealed dense and tortuous blood vessels with results consistent with histological features 
and recent studies that indicate angiogenesis in dysplasia. To our knowledge, this is the first 
time TPL of GNRs has been used to image in vivo features in a cancer model and also the first 
time the abnormal vasculature of precancerous lesions has been visualized by intravital 
microscopy. These initial results suggest that GNRs can function as high-contrast imaging 
agents for visualization of in vivo features of carcinogenesis, with potential applications to be 
explored in studies of carcinogenesis, development of therapeutic approaches providing real-
time feedback of effects, and/or diagnostics. While the goal of the current study was to 
demonstrate advantages of nontargeted GNRs for in vivo cancer imaging, it will be of interest 
to pursue in vivo molecular targeting to specific biomarkers which could prove useful in early 
diagnostics or studies of pathogenesis in oral carcinogenesis. 
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